Favorable Outcome of Juvenile Dermatomyositis Treated without Systemic Corticosteroids - 07/03/14
, C. April Bingham, MD b, Philip J. Kahn, MD c, Andrew H. Eichenfield, MD a, Lisa F. Imundo, MD a
Reprints not available. Correspondence to Dr Deborah Levy, Morgan Stanley Children’s Hospital of New York-Presbyterian, 3959 Broadway, CHN 106, New York, NY 10032.Abstract |
Objective |
To describe the course of patients with juvenile dermatomyositis (JDM) treated effectively without systemic corticosteroids.
Study design |
A retrospective study of 38 patients with JDM treated at a tertiary care children’s hospital identified 8 patients who had never received corticosteroids. Disease presentation and course, pharmacologic, and ancillary treatments were recorded.
Results |
Patients in the no corticosteroid group were followed for a median of 2.8 years (range, 2.1 to 9.5 years). Treatment was primarily with intravenous immunoglobulin (IVIG) (75%) and methotrexate (50%), with favorable response in all. No serious treatment complications were observed; headaches were reported by 3 patients receiving IVIG. Two patients had a myositis flare after discontinuing all medications for more than 1 year; complete resolution of symptoms was observed after either 1 or 2 further doses of IVIG. Two patients had calcinosis (at 1 and 9 years of disease); however, no patient had joint contractures, muscle atrophy, lipodystrophy, or functional limitations.
Conclusions |
Systemic corticosteroids can be avoided in a select group of patients with JDM. Alternative agents such as methotrexate and IVIG may be prescribed to effectively treat JDM and prevent complications.
Le texte complet de cet article est disponible en PDF.Mots-clés : ALT, ANA, AST, BMI, CMAS, CPK, CUMC, DsDNA, ENA, IVIG, JDM, LDH, MMT, MTX
Plan
| The authors declare no financial or other relationships that might lead to a conflict of interest |
Vol 156 - N° 2
P. 302-307 - février 2010 Retour au numéro
Article précédent
- Adrenal Cortisol Secretion Capacity in Children and Adolescents with New-Onset, Mild Crohn’s Disease
- Amnon Zung, Michal Kori, Gabriel Dinary, Efrat Broide, Baruch Yerushalmi, Arie Levine
- Enhanced Insulin Sensitivity in Prepubertal Children with Constitutional Delay of Growth and Development
- Dyanne A. Wilson, Paul L. Hofman, Harriet L. Miles, Tim A. Sato, Nathalie E. Billett, Elizabeth M. Robinson, Wayne S. Cutfield
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?